Your browser doesn't support javascript.
loading
Amiselimod, a sphingosine 1-phosphate receptor-1 modulator, for systemic lupus erythematosus: A multicenter, open-label exploratory study.
Tanaka, Yoshiya; Kondo, Kazuoki; Ichibori, Ayako; Yanai, Yoshiari; Susuta, Yutaka; Inoue, Shinsuke; Takeuchi, Tsutomu.
Affiliation
  • Tanaka Y; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
  • Kondo K; Ikuyaku, Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Ichibori A; Ikuyaku, Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Yanai Y; Ikuyaku, Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Susuta Y; Ikuyaku, Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Inoue S; Ikuyaku, Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Takeuchi T; The Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Lupus ; 29(14): 1902-1913, 2020 Dec.
Article in En | MEDLINE | ID: mdl-33115374

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sphingosine-1-Phosphate Receptors / Lupus Erythematosus, Systemic Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Lupus Journal subject: REUMATOLOGIA Year: 2020 Type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sphingosine-1-Phosphate Receptors / Lupus Erythematosus, Systemic Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Lupus Journal subject: REUMATOLOGIA Year: 2020 Type: Article Affiliation country: Japan